Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
12/2008
12/17/2008CN100443476C Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
12/16/2008US7465726 Substituted pyrrolo[2.3-B]pyridines
12/16/2008US7465722 Biphenyl vasopressin agonists
12/11/2008WO2007102936A3 Polynucleotides for production of farnesyl dibenzodiazepinones
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306050 Aminodiazepines as Toll-Like Receptor Modulators
12/11/2008US20080306049 Therapeutic pyrazoloquinoline derivatives
12/11/2008US20080306048 Therapeutic pyrazoloquinoline urea derivatives
12/11/2008US20080306046 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative
12/11/2008US20080305082 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof
12/09/2008US7462608 Non nucleoside reverse transcriptase inhibitors
12/04/2008WO2008145010A1 Preparation methods of 4-acetyl-2,3,4,5-tetrahydro- benzo[1,4]diazepine and their intermediates
12/04/2008WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
12/04/2008WO2008144981A1 Methods and intermediates for preparing 4-acetyl-2,3,4,5-tetrahydro-1h-1,4-benzodiazepine
12/04/2008WO2008082887A3 Inhibitors of poly(adp-ribose)polymerase
12/04/2008US20080300237 Pharmaceutically Active Diazepanes
12/04/2008CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
12/03/2008EP1997804A1 Mmp-13-selective inhibitor
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/02/2008US7459558 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
12/02/2008US7459552 Reacting N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide with 5-benzyloxy-2-mercaptobenzimidazole in presence of triphenylphosphine and diethyl azodicarboxylate; acyl-coenzyme A cholesterol acyltransferase (ACAT) inhibitor
12/02/2008CA2359646C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-.beta.-cyclodextrin or 2-hydroxypropyl-.beta.-cyclodextrin and method
11/2008
11/27/2008WO2008142591A2 3- to 7-membered 1,3-diaza-4-oxo-heterocyclic derivatives capable of releasing active aldehydes or ketones
11/27/2008US20080293700 Compositions and Methods Relating to Novel Compounds and Targets Thereof
11/27/2008US20080293699 Inhibitors of thapsigargin-induced cell death
11/27/2008US20080293692 Amidating a succinamic acid with a 3-aminolactam to prepare compounds, such as N1-[1,3-dihydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(allyl)-butanediamide
11/25/2008US7456278 Lactams substituted by cyclic succinates as inhibitors of Aβ protein production
11/25/2008US7456172 Succinoylamino benzodiazepines as inhibitors of Aβ protein production
11/25/2008US7456169 Heterocyclic kinase inhibitors
11/19/2008EP1660462B1 8-chloro-2,3-benzodiazepine derivatives
11/19/2008CN101309671A Stable composition for a pharmaceutical formulation containing olanzapine
11/18/2008CA2516557C Triazole compounds useful in therapy
11/18/2008CA2301646C Pharmaceutical suspension comprising nevirapine hemihydrate
11/18/2008CA2221517C Synthesis of n-substituted oligomers
11/13/2008WO2008136754A1 Novel benzyl - 2 -oxo-piperazinyl/ 7-oxo/5-oxa- [1,4] diazepanyl/ 2 -oxo- tetrahydropyrimidinyl derivatives
11/13/2008US20080279917 Bisbenzamidines for the Treatment of Pneumonia
11/12/2008EP1989188A1 Therapeutic piperazines as pde4 inhibitors
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008CN101304980A 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepine-2(1H)-one
11/12/2008CN101304743A Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
11/06/2008WO2008134228A1 Benzoxazole compounds
11/06/2008WO2008133155A1 Bicyclic heterocyclic compound
11/06/2008US20080275028 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
11/06/2008US20080275024 Amyloid precursor protein/gamma-secretase inhibitors; amides of aminobenzodiazepines: 2-(3,5-difluorophenyl)-N {[N-(1-methyl-2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))carbamoyl]cyclohexyl}acetamide
11/06/2008US20080275023 N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/2008
10/30/2008WO2008128889A1 Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
10/30/2008US20080269202 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
10/30/2008US20080269194 Benzodiazepine compounds; controlling cell death, autoimmune diseases; antiinflammatory agents; antiproliferative agents; antiarthritic agents; multiple sclerosis;Crohn's disease; leukemia; inflammatory bowel disorders; anticancer, antitumor agents; asthma; psoriasis
10/30/2008CA2684760A1 Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
10/29/2008EP1983997A2 Crystalline forms of a farnesyl dibenzodiazepinone
10/29/2008EP1556055B1 Cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure and their use in therapy
10/29/2008CN101296910A Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
10/28/2008US7442791 Aminoalkylamide substituted cyclohexyl derivatives
10/28/2008US7442704 Amide derivatives
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261957 3'-(8-Methyl-4-oxo-7-trifluoromethyl-4,5-dihydro-3H-benzo[b][1,4]diazepin-2-yl)-biphenyl-4-sulfonic acid amide; metabotropic glutamate receptor antagonist; prodrug; advantages in absorption, pharmacokinetics, in distribution and transport to brain; central nervous system disorder
10/23/2008US20080261956 Substituted Phenols as Active Agents Inhibiting Vegf Production
10/23/2008US20080261948 Ligands for G-Protein Coupled Receptors
10/23/2008US20080261900 Fluoroquinolones
10/22/2008EP1594879B1 Process and intermediates for the preparation of olanzapine
10/16/2008WO2008124075A1 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
10/15/2008EP1979308A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
10/15/2008CN101287716A Aminodiazepines as toll-like receptor modulators
10/09/2008US20080249301 Regioselective Process for Preparing Benzimidazole Thiophenes
10/08/2008EP1976840A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
10/08/2008EP1976828A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
10/02/2008WO2008117796A1 Novel mutilin derivatives
09/2008
09/30/2008US7429659 Isopropyl-piperazin-1-yl)-(5-piperidin-1-ylmethyl-furan-2-yl)-methanone; 5-(4-Fluoro-piperidin-1-ylmethyl)-furan-2-yl]-(4-isopropyl-piperazin-1-yl)-methanone, fumarate salt; insomnia, attention deficit hyperactivity disorders, learning disorders, cognitive dysfunction, eating disorders, obesity
09/30/2008US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation
09/25/2008US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis
09/25/2008US20080234247 Heterocyclic analgesic compounds and methods of use thereof
09/24/2008CN101273021A Selected CGRP antagonists, methods for the production thereof and their use as medicaments
09/24/2008CN101270093A Novel method for synthesizing 2,3,4,5-tetrahydric--1H-1,4-benzodiazepine
09/23/2008US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
09/18/2008US20080227976 Process for producing chirally enriched aspartic and glutamic acid derivatives by subjecting a diazoketone derivative to conditions that effect rearrangement to form the corresponding homologation product; useful for preparing compounds that are caspase inhibitors
09/18/2008US20080227773 N-[4-(1,4-Diaza-bicyclo[3.2.2]non-4-yl)-phenyl]-benzamide; disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse
09/18/2008US20080227772 Diazabicyclic Aryl Derivatives as Nicotinic Acetylcholine Receptor Ligands
09/18/2008CA2783589A1 Compositions and methods relating to novel compounds and targets thereof
09/17/2008EP1968953A2 Method for isolating (r)-tofisopam
09/17/2008EP1968952A2 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepine-2(1h)-one
09/17/2008CN101267825A Benzodiazepine derivatives for treating hepatitis C infection
09/17/2008CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases
09/17/2008CN100418955C Novel Benzo-fused heterocycles
09/16/2008US7425627 Methods of synthesizing olanzapine
09/11/2008US20080221327 Synthesis of glyt-1 inhibitors
09/11/2008US20080221087 Substituted lactams as inhibitors of abeta protein production
09/11/2008US20080221085 Nicotinic Receptor Agonists for the Treatment of Inflammatory Diseases
09/10/2008EP1778649A4 A PROCESS FOR PRODUCING PURE FORM OF 2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3-b][1,5]BENZODIAZEPINE
09/10/2008CN101263127A Piperazine derivatives
09/09/2008US7423033 Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein production
09/04/2008WO2008106128A2 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
09/04/2008US20080214526 Macrocyclic Compounds and Compositions Useful as Bace Inhibitors
09/04/2008US20080210858 High Stability Polyionic Liquid Salts
09/04/2008CA2678577A1 Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
09/03/2008CN101257948A Pyrimidine-fused diazepine derivatives and indole-fused pteridines
09/02/2008US7419976 Diazepanes derivatives useful as IFA inhibitors
09/02/2008US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2008
08/28/2008US20080207602 Succinoylamino benzodiazepines as inhibitors of abeta protein production
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 60